Changes in severity of 2009 pandemic A/H1N1 influenza in England: A Bayesian evidence synthesis

BMJ (Online)

Volumn 343, Issue 7824, 2011, Pages

  Presanis, A M ^a   Pebody, R G ^b   Paterson, B J ^b,c   Tom, B D M ^a   Birrell, P J ^a   Charlett, A ^b   Lipsitch, M ^d   De Angelis, D ^a,b  

^a MRC BIOSTATISTICS UNIT   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BAYES THEOREM; CHILD; CONSULTATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DATA BASE; DISEASE SEVERITY; DISEASE SURVEILLANCE; EPIDEMIOLOGICAL DATA; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HEALTH SERVICE; HOSPITALIZATION; HUMAN; INFANT; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROBABILITY; SCHOOL CHILD; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; AGED; BAYES THEOREM; CHILD; CHILD, PRESCHOOL; ENGLAND; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; MIDDLE AGED; PANDEMICS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84859005393     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d5408     Document Type: Article

References (37)

1. World Health Organization. Pandemic (H1N1) 2009 - update 112. 2010. www.who.int/csr/don/2010-08-06/en/index.html.
2. Lipsitch M, Riley S, Cauchemez S, Ghani A, Ferguson N. Managing and reducing uncertainty in an emerging influenza pandemic. N Engl J Med 2009;361:112-5.
3. Garske T, Legrand J, Donnelly C, Ward H, Cauchemez S, Fraser C, et al. Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ 2009;339:b2840.
4. Nishiura H, Klinkenberg D, Roberts M, Heesterbeek J. Early epidemiological assessment of the virulence of emerging infectious diseases: a case study of an influenza pandemic. PloS One 2009;4:e6852.
5. Reed C, Angulo F, Swerdlow D, Lipsitch M, Meltzer M, Jernigan D, et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerging Infect Dis 2009;15:2004-7.
6. Wilson N, Baker MG. The emerging influenza pandemic: estimating the case fatality ratio. Euro Surveill 2009;14:pii=19255.
7. Baker MG, Wilson N, Huang QS, Paine S, Lopez L, Bandaranayake D, et al. Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill 2009;14:pii=19319.
8. Presanis AM, De Angelis D, Hagy A, Reed C, Riley S, Cooper B, et al. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med 2009;6:e1000207.
9. Miller MA, Viboud C, Balinska M, Simonsen L. The signature features of influenza pandemics - implications for policy. N Engl J Med 2009;360:2695-8.
10. Health Protection Agency. Antiviral drugs for seasonal flu approved as HPA urges at-risk groups to get vaccinated. Health Protection Agency Press Release. 2010. www.hpa.org.uk/NewsCentre/NationalPressReleases/ 2010PressReleases/101213flu/.
11. Welliver R, Monto A, Carewicz O, Schatteman E, Hassman M, Hedrick J, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA 2001;285:748-54. (Pubitemid 32167233)
12. Carrat F, Vergu E, Ferguson N, Lemaitre M, Cauchemez S, Leach S, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008;167:775-85. (Pubitemid 351451744)
13. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010;375:1100-8.
14. Donaldson L, Rutter P, Ellis B, Greaves F, Mytton O, Pebody R, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009;339:b5213.
15. Pebody RG, McLean E, Zhao H, Cleary P, Bracebridge S, Foster K, et al. Pandemic influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill 2010;15:pii.
16. Health Protection Agency, Health Protection Scotland, Communicable Disease Surveillance Centre, National Public Health Service for Wales. First few hundred (FF100) project: epidemiological protocols for comprehensive assessment of early swine influenza cases in the United Kingdom. 2009. www.hpa.org.uk/web/HPAwebFile/HPAweb-C/1257260453727.
17. Health Protection Agency. Epidemiological report of pandemic (H1N1) 2009 in the UK. 2010. www.hpa.org.uk/Publications/InfectiousDiseases/Influenza/ 1010EpidemiologicalreportofpandemicH1N12009inUK/.
18. Presanis AM. The role of each item of evidence in estimating severity of novel pandemic (H1N1) 2009 influenza: a Bayesian synthesis. In preparation, 2011.
19. Health Protection Agency. Method used to estimate new pandemic (H1N1) 2009 influenza cases in England. 2009. www.hpa.org.uk/web/ HPAweb&Page&HPAwebAutoListName/Page/1259151885940.
20. Evans BG, Charlett A, Powers C, Zhao H, Bermingham A, Smith G, et al. Has estimation of numbers of cases of pandemic influenza H1N1 in England in 2009 provided a useful measure of the occurrence of disease? In preparation,2011.
21. Hardelid P, Andrews NJ, Hoschler K, Stanford E, Baguelin M, Waight PA, et al. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess 2010;14:115-92.
22. Campbell CN, Mytton OT, McLean EM, Rutter PD, Pebody RG, Sachedina N, et al. Hospitalization in two waves of pandemic influenza A(H1N1) in England. Epidemiol Infect 2010;26:1-10.
23. Grant A. Pandemic influenza deaths: capture-recapture estimate. Personal communication, 2010.
24. Lunn D, Spiegelhalter D, Thomas A, Best N. The BUGS project: evolution, critique and future directions (with discussion). Stat Med 2009;28:3049-82.
25. Ihekweazu C. Clinical spectrum of disease caused by novel pandemic (H1N1) 2009 in a closed population setting: a sero-epidemiological study. International Conference on Emerging Infectious Diseases, Atlanta, 2010.
26. Influenzanet. FluSurvey. 2009. www.flusurvey.org.uk/.
27. FluWatch. Pandemic study. 2009. www.fluwatch.co.uk/.
28. Degail M. Concurrent invasive bacterial infections in confirmed pandemic (H1N1) 2009 influenza cases in England, 2009-2010. Health Protection Conference, 2010.
29. Dowell S, Whitney C, Wright C, Rose C, Schuchat A. Seasonal patterns of invasive pneumococcal disease. Emerging Infect Dis 2003;9:573-9. (Pubitemid 36529516)
30. Wallinga J, Van Boven M, Lipsitch M. Optimizing infectious disease interventions during an emerging epidemic. Proc Natl Acad Sci USA 2010;107:923-8.
31. Birrell PJ, Ketsetzis G, Gay NJ, Cooper BS, Presanis AM, Harris RJ, et al. Bayesian modelling to unmask and predict the influenza A/H1N1pdm dynamics in London. Submitted,2011.
32. Bird SM. Like-with-like comparisons? Comment on Miller et al. Lancet 2010;376:684.
33. Cowling BJ, Chan KH, Fang VJ, Lau LLH, So HC, Fung ROP, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010;362:2175-84.
34. Bandaranayake D, Bissielo A, Huang S, Wood T. Seroprevalence of the 2009 influenza A (H1N1) pandemic in New Zealand. 2010. www.moh.govt.nz/moh.nsf/ pagesmh/10124/$File/seroprevalence-flu-2009.pdf.
35. Harris R, Kafatos G. Statistical analysis preliminary report: FF100 serology. Health Protection Agency internal report, 2010.
36. Hadler JL, Konty K, McVeigh KH, Fine A, Eisenhower D, Kerker B, et al. Case fatality rates based on population estimates of influenza-like illness due to novel H1N1 influenza: New York City, May-June 2009. PloS One 2010;5:e11677.
37. Wu JT, Ma ESK, Lee CK, Chu DKW, Ho PL, Shen AL, et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 2010;51:1184-91.